Myopia Management Focus of Pipeline Expansion for Leo Lens Pharma

Leo Lens Pharma Strengthens its Pipeline with New IP Protection for a Unique Atropine-based Myopia Management Solution February 19, 2020 08:51 AM Eastern Standard Time SAN DIEGO–(BUSINESS WIRE)–Today, Leo Lens Pharma (formerly DBA as Leo Lens Technology Co., Inc.) announced it received a notice of allowance from the USPTO for a patent for the use […]

Biocom Member Spotlight: Interview with Kokila & Praful Doshi, Co-Founders of Leo Lens Technology

Leo Lens was featured in a Member Spotlight article from Biocom. Read it here:

Leo Lens Selected as Presenting Company at Octane MTIF 2018

Leo Lens was selected from over 150 companies to be a presenting company at Octane’s 2018 Medical Technology Innovation Forum. For more information on the event go to